Massachusetts General Hospital: Tobacco Use Disorder trials

The registry lists 24 Tobacco Use Disorder studies with Massachusetts General Hospital as lead sponsor. 4 are open to participants now and 8 have results posted.

Phase 2 2Phase 3 1Phase 4 5No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Community Health Worker Support to Help People With Serious Mental Illness to Quit SmokingNot yet recruitingNCT07789132Not applicable
• Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)RecruitingNCT07145866Phase 4
• Behavioral Intervention for Youth to Promote Vaping CessationRecruitingNCT06765291Not applicable
• Adapting and Pilot Testing a Skills-based Smoking Cessation Intervention to Address Developmental and Health-related Stress Among Adults Who SmokeRecruitingNCT06654414Not applicable
• Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer ScreeningCompletedNCT06472869Not applicableResults posted
• Varenicline for Nicotine Vaping Cessation in AdolescentsCompletedNCT05367492Phase 4Results posted
• Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper AdolescentsTerminatedNCT04602494Phase 4Results posted
• Comparative Effectiveness of Post-Discharge Strategies for Hospitalized SmokersCompletedNCT01714323Not applicableResults posted
• Integrated Treatment for Smoking Cessation & Anxiety in People With HIVCompletedNCT01393301Not applicableResults posted
• Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse PreventionCompletedNCT01188967Phase 2Results posted
• Memory Reconsolidation Blockade as a Novel Intervention for Nicotine DependenceCompletedNCT00916721Phase 3Results posted
• Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to SmokingCompletedNCT00218465Phase 2Results posted
• A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar DisorderActive, not recruitingNCT06609902Not applicable
• Assessment of Biomarkers in Children to Help Parents Quit TobaccoCompletedNCT04832659Not applicable
• Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIVCompletedNCT03904186Not applicable
• Proactive Population Health Strategy to Offer Tobacco Dependence Treatment to SmokersCompletedNCT03612895Not applicable
• Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.CompletedNCT02601521Not applicable
• Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMICompletedNCT01982617Not applicable
• Changing Pediatric Office Systems Nationally to Address Parental Tobacco UseCompletedNCT01882348Not applicable
• Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With SchizophreniaTerminatedNCT01576640Phase 4
• Direct to Smoker Outreach in a Health Care SettingCompletedNCT01321944Not applicable
• Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in SmokersStatus unknownNCT01314378Not applicable
• Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop SmokingCompletedNCT00664261Not applicable
• Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding WomenTerminatedNCT00119210Phase 4